XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Period Of Adoption Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period Of Adoption Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect Period Of Adoption Adjustment
Beginning balance at Jun. 30, 2020 $ 710,719   $ 2 $ 857,044   $ 2,420 $ (148,747)  
Beginning balance, shares at Jun. 30, 2020     79,635          
Issuance of common stock upon exercise of stock options and release of restricted stock units 8,081     8,081        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     1,164          
Issuance of common stock under the employee stock purchase plan 4,327     4,327        
Issuance of common stock under the employee stock purchase plan, shares     226          
Stock-based compensation 9,894     9,894        
Other comprehensive loss (1,302)         (1,302)    
Net loss (12,951)           (12,951)  
Ending balance at Sep. 30, 2020 718,768   $ 2 879,346   1,118 (161,698)  
Ending balance, shares at Sep. 30, 2020     81,025          
Beginning balance at Jun. 30, 2020 710,719   $ 2 857,044   2,420 (148,747)  
Beginning balance, shares at Jun. 30, 2020     79,635          
Net loss (56,858)              
Ending balance at Mar. 31, 2021 870,461   $ 2 1,076,255   (191) (205,605)  
Ending balance, shares at Mar. 31, 2021     83,090          
Beginning balance at Sep. 30, 2020 718,768   $ 2 879,346   1,118 (161,698)  
Beginning balance, shares at Sep. 30, 2020     81,025          
Equity component of 2025 Notes, net of allocated issuance costs and taxes 245,066     245,066        
Issuance of common stock upon exercise of stock options and release of restricted stock units 8,184     8,184        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     1,089          
Purchase of capped calls (87,860)     (87,860)        
Stock-based compensation 10,689     10,689        
Other comprehensive loss (920)         (920)    
Net loss (17,179)           (17,179)  
Ending balance at Dec. 31, 2020 876,748   $ 2 1,055,425   198 (178,877)  
Ending balance, shares at Dec. 31, 2020     82,114          
Issuance of common stock upon exercise of stock options and release of restricted stock units 5,613     5,613        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     756          
Issuance of common stock under the employee stock purchase plan 4,537     4,537        
Issuance of common stock under the employee stock purchase plan, shares     220          
Stock-based compensation 10,680     10,680        
Other comprehensive loss (389)         (389)    
Net loss (26,728)           (26,728)  
Ending balance at Mar. 31, 2021 870,461   $ 2 1,076,255   (191) (205,605)  
Ending balance, shares at Mar. 31, 2021     83,090          
Beginning balance at Jun. 30, 2021 2,529,590   $ 2 2,777,155   (100) (247,467)  
Beginning balance (ASU 2020-06) at Jun. 30, 2021   $ (216,066)     $ (245,066)     $ 29,000
Beginning balance, shares at Jun. 30, 2021     94,504          
Issuance of common stock upon public offering, net of underwriting discounts and commissions and other offering costs 1,341,122     1,341,122        
Issuance of common stock upon public offering, net of underwriting discounts and commissions and other offering costs, shares     5,074          
Issuance of common stock as consideration for an acquisition,net of issuance costs 488,263     488,263        
Issuance of common stock as consideration for an acquisition, net of issuance costs, shares     1,788          
Fair value of replacement awards 26,710     26,710        
Issuance of common stock upon exercise of stock options and release of restricted stock units 8,644     8,644        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     1,033          
Issuance of common stock under the employee stock purchase plan 5,726     5,726        
Issuance of common stock under the employee stock purchase plan, shares     40          
Purchase of capped calls (37,893)     (37,893)        
Stock-based compensation 38,839     38,839        
Other comprehensive loss (39)         (39)    
Net loss (75,685)           (75,685)  
Ending balance at Sep. 30, 2021 4,109,211   $ 2 4,403,500   (139) (294,152)  
Ending balance (ASU 2021-08) at Sep. 30, 2021   1,426           1,426
Ending balance, shares at Sep. 30, 2021     102,439          
Beginning balance at Jun. 30, 2021 2,529,590   $ 2 2,777,155   (100) (247,467)  
Beginning balance (ASU 2020-06) at Jun. 30, 2021   $ (216,066)     $ (245,066)     $ 29,000
Beginning balance, shares at Jun. 30, 2021     94,504          
Net loss (241,419)              
Ending balance at Mar. 31, 2022 4,068,316   $ 2 4,535,699   (7,499) (459,886)  
Ending balance, shares at Mar. 31, 2022     104,183          
Beginning balance at Sep. 30, 2021 4,109,211   $ 2 4,403,500   (139) (294,152)  
Beginning balance, shares at Sep. 30, 2021     102,439          
Issuance of common stock upon exercise of stock options and release of restricted stock units 14,140     14,140        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     1,022          
Stock-based compensation 50,701     50,701        
Other comprehensive loss (1,711)         (1,711)    
Net loss (80,440)           (80,440)  
Ending balance at Dec. 31, 2021 4,093,327   $ 2 4,468,341   (1,850) (373,166)  
Ending balance, shares at Dec. 31, 2021     103,461          
Issuance of common stock upon exercise of stock options and release of restricted stock units 6,332     6,332        
Issuance of common stock upon exercise of stock options and release of restricted stock units, shares     680          
Issuance of common stock under the employee stock purchase plan 7,123     7,123        
Issuance of common stock under the employee stock purchase plan, shares     42          
Stock-based compensation 53,903     53,903        
Other comprehensive loss (5,649)         (5,649)    
Net loss (86,720)           (86,720)  
Ending balance at Mar. 31, 2022 $ 4,068,316   $ 2 $ 4,535,699   $ (7,499) $ (459,886)  
Ending balance, shares at Mar. 31, 2022     104,183